SCHEMBL25540705

SCHEMBL25540705

Nc1cc(-c2ccccc2)c(-n2c3ccccc3c3cc(-c4ccc5oc6ccccc6c5c4)ccc32)c(-c2ccccc2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.44
KDM4E B2RXH2 3/20 0.44
MEN1 O00255 3/20 0.44
ALDH1A1 P00352 3/20 0.44
MAPT P10636 3/20 0.44
HPGD P15428 3/20 0.44
NPC1 O15118 3/20 0.44
RAB9A P51151 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
PLA2G2A P14555 3/20 0.37
PLA2G4A P47712 3/20 0.37
PLA2G10 O15496 1/20 0.36
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CHEK2 O96017 1/20 0.34
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33
HSP90AA1 P07900 1/20 0.33
HSP90AB1 P08238 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25540717 0.88 PLA2G2A (0.37) KMT2AKDM4EMEN1ALDH1A1MAPT
SCHEMBL25540501 0.87 TSPO (0.40) KMT2AKDM4EMEN1ALDH1A1MAPT
SCHEMBL21599964 0.85 PLA2G2A (0.38) KMT2AKDM4EMEN1ALDH1A1MAPT
SCHEMBL25539894 0.85 PLA2G2A (0.35) KMT2AKDM4EMEN1ALDH1A1MAPT
SCHEMBL21599973 0.84 PLA2G2A (0.37) KMT2AKDM4EMEN1ALDH1A1MAPT
SCHEMBL21599958 0.84 PLA2G2A (0.37) KMT2AKDM4EMEN1ALDH1A1MAPT
SCHEMBL22198427 0.84 PLA2G2A (0.37) KMT2AKDM4EMEN1ALDH1A1MAPT
SCHEMBL25540646 0.84 KDM4E (0.49) KMT2AKDM4EMEN1ALDH1A1MAPT
SCHEMBL25539896 0.83 PLA2G2A (0.36) KMT2AKDM4EMEN1ALDH1A1MAPT
SCHEMBL25540701 0.83 MAPT (0.44) KMT2AMEN1MAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159570-A1 LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE HETEROCYCLIC COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2023-05-25 US disclosed
US-20230159570-A1 LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE HETEROCYCLIC COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159570-A1 LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE HETEROCYCLIC COMPOUND CRY1, CYP1A1, NQO1 KMT2A 1759/4885KDM4E 3633/4885MEN1 241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.